Functional implications of membrane modification with semenogelins for inhibition of sperm motility in humans

Cell Motility and the Cytoskeleton

Volumn 66, Issue 2, 2009, Pages 99-108

  Yoshida, Kaoru ^a   Krasznai, Zoárd Tibor ^b   Krasznai, Zoltán ^b   Yoshiike, Miki ^c   Kawano, Natsuko ^d   Yoshida, Manabu ^d   Morisawa, Masaaki ^e   Tóth, Zoltán ^b   Bazsáné, Zsuzsa Kassai ^b   Márián, Teréz ^b   Iwamoto, Teruaki ^c,f  

^a TOIN UNIVERSITY OF YOKOHAMA   (Japan)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e TOKYO KASEI GAKUIN UNIVERSITY   (Japan)

^f INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Male infertility; Membrane permeability; Membrane potential; Semen coagulum

Indexed keywords

CELL MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; SEMENOGELIN; SYNAPSIN I; UNCLASSIFIED DRUG;

ANALYZER; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; CELL MEMBRANE; CELL MOTILITY; COMPUTER AIDED DESIGN; CONFOCAL MICROSCOPY; DOSE RESPONSE; EJACULATION; ELECTRIC POTENTIAL; EVALUATION; FLOW CYTOMETRY; FLOW MEASUREMENT; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HYPERPOLARIZATION; INFORMATION; LIQUEFACTION; MALE; MALE INFERTILITY; MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; MEMBRANE STRUCTURE; METHODOLOGY; MOTION; NORMAL HUMAN; PARAMETER; PRIORITY JOURNAL; PROSTATE; PROTEIN BINDING; REGULATORY MECHANISM; SEMEN ANALYSIS; SPERMATOZOON MOTILITY; VOLUNTEER;

CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; HUMANS; MALE; MEMBRANE POTENTIALS; SEMEN; SEMINAL VESICLE SECRETORY PROTEINS; SPERM MOTILITY;

EID: 59949098466     PISSN: 08861544     EISSN: 10970169     Source Type: Journal    
DOI: 10.1002/cm.20329     Document Type: Article

References (29)

1. al-Somai N, Vishwanath R, Shannon P, Molan PC. 1994. Low molecular weight components in bovine semen diffusate and their effects on motility of bull sperm. Reprod Fertil Dev 6:165-171.
2. Bjartell A, Malm J, Moller C, Gunnarsson M, Lundwall A, Lilja H. 1996. Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immu-nocytochemistry. J Androl 17:17-26.
3. de Lamirande E. 2007. Semenogelin, the main protein of the human semen coagulum, regulates sperm function. Semin Thromb Hemost 33:60-68.
4. de Lamirande E, Gagnon C. 1984. Origin of a motility inhibitor within the male reproductive tract. J Androl 5:269-276.
5. de Lamirande E, Bardin CW, Gagnon C. 1983. Aprotinin and a seminal plasma factor inhibit the motility of demembranated reactivated rabbit spermatozoa. Biol Reprod 28:788-796.
6. Guzman-Grenfell AM, Bonilla-Hernandez MA, Gonzalez-Martinez MT. 2000. Glucose induces a Na(+), K(+)-ATPase-dependent transient hyperpolarization in human sperm. I. Induction of changes in plasma membrane potential by the proton ionophore CCCP. Biochim Biophys Acta 1464:188-198.
7. Hajdu P, Varga Z, Pieri C, Panyi G, Gaspar R, Jr. 2003. Cholesterol modifies the gating of Kv1.3 in human T lymphocytes. Pflugers Arch 445:674-682.
8. Iwamoto T, Gagnon C. 1988a. A human seminal plasma protein blocks the motility of human spermatozoa. J Urol 140:1045-1048.
9. Iwamoto T, Gagnon C. 1988b. Purification and characterization of a sperm motility inhibitor in human seminal plasma. J Androl 9:377-383.
10. Iwamoto T, Tsang A, Luterman M, Dickson J, de Lamirande E, Okuno M, Mohri H, Gagnon C. 1992. Purification and characterization of a sperm motility-dynein ATPase inhibitor from boar seminal plasma. Mol Reprod Dev 31:55-62.
11. Jeng H, Liu KM, Chang WC. 1993. Purification and characterization of reversible sperm motility inhibitors from porcine seminal plasma. Biochem Biophys Res Commun 191:435-440.
12. Koistinen H, Soini T, Leinonen J, Hyden-Granskog C, Salo J, Halttunen M, Stenman UH, Seppala M, Koistinen R. 2002. Monoclonal antibodies, immunofluorometric assay, and detection of human semenogelin in male reproductive tract: No association with in vitro fertilizing capacity of sperm. Biol Reprod 66:624-628.
13. Krasznai Z. 2005. Ion channels in T cells: From molecular pharmacology to therapy. Arch Immunol Ther Exp (Warsz) 53:127-135.
14. Krasznai Z, Márián T, Balkay L, Emri M, Trón L. 1995. Flow cyto-metric determination of absolute membrane potential of cells. J Photochem Photobiol B 28:93-99.
15. Krasznai Z, Morisawa M, Krasznai ZT, Morisawa S, Inaba K, Baz-sane ZK, Rubovszky B, Bodnar B, Borsos A, Marian T. 2003. Gadolinium, a mechano-sensitive channel blocker, inhibits osmosis-initiated motility of sea- and freshwater fish sperm, but does not affect human or ascidian sperm motility. Cell Motil Cytoskeleton 55:232-243.
16. Krasznai Z, Krasznai ZT, Morisawa M, Bazsane ZK, Hernadi Z, Faze-kas Z, Tron L, Goda K, Marian T. 2006. Role of the Na+/Ca2+ exchanger in calcium homeostasis and human sperm motility regulation. Cell Motil Cytoskeleton 63:66-76.
17. Lilja H, Abrahamsson PA, Lundwall A. 1989. Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa. J Biol Chem 264:1894-1900.
18. Marian T, Krasznai Z, Balkay L, Balazs M, Emri M, Bene L, Tron L. 1993. Hypo-osmotic shock induces an osmolality-dependent permeabilization and structural changes in the membrane of carp sperm. J Histochem Cytochem 41:291-297.
19. Miyano S, Yoshida K, Yoshiike M, Miyamoto C, Furuichi Y, Iwamoto T. 2003. A large deletion of the repeat site in semenogelin I is not involved in male infertility. Int J Mol Med 11:435-440.
20. Peitz B. 1988. Effects of seminal vesicle fluid components on sperm motility in the house mouse. J Reprod Fertil 83:169-176.
21. Peter A, Lilja H, Lundwall A, Malm J. 1998. Semenogelin I and seme-nogelin II, the major gel-forming proteins in human semen, are substrates for transglutaminase. Eur J Biochem 252:216-221.
22. Robert M, Gagnon C. 1996. Purification and characterization of the active precursor of a human sperm motility inhibitor secreted by the seminal vesicles: Identity with semenogelin. Biol Reprod 55:813-821.
23. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Pro-venzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
24. Szabó G, Jr., Kiss A, Trón L. 1982. Permeabilization of lymphocytes with polyethylene glycol 1000. Discrimination of permeabil-ized cells by flow cytometry. Cytometry 3:59-63.
25. Szekely A, Kitajka K, Panyi G, Marian T, Gaspar R, Krasznai Z. 2007. Nutrition and immune system: Certain fatty acids differently modify membrane composition and consequently kinetics of KV1.3 channels of human peripheral lymphocytes. Immu-nobiology 212:213-227.
26. Ulvsback M, Lazure C, Lilja H, Spurr NK, Rao VV, Loffler C, Hans-mann I, Lundwall A. 1992. Gene structure of semenogelin I and II. The predominant proteins in human semen are encoded by two homologous genes on chromosome 20. J Biol Chem 267:18080-18084.
27. WHO. 1999. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. Cambridge: Cambridge University Press.
28. Yoshida K, Yamasaki T, Yoshiike M, Takano S, Sato I, Iwamoto T. 2003. Quantification of seminal plasma motility inhibitor/ semenogelin in human seminal plasma. J Androl 24:878-884.
29. Yoshida K, Kawano N, Yoshiike M, Yoshida M, Iwamoto T, Mori-sawa M. 2008. Physiological roles of semenogelin I and zinc in sperm motility and semen coagulation on ejaculation in humans. Mol Hum Reprod 14:151-156.